Not just naughty: 50 years of stimulant drug advertising

Medicating Modern America: Prescription Drugs in History

Volumn , Issue , 2007, Pages 131-155

  Singh, Ilina ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900292305     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (51)

1. Healy, D. (2000). The Psychopharmacologists vol 3. London: Arnold, pp. 333-356;
2. Rose, N. (2004). Becoming neurochemical selves. In Nico Stehr, ed. Biotechnology, Commerce and Civil Society, pp. 89-128. New Brunswick, NJ: TransactionPublishers, 2004.
3. International Narcotics Control Board (INCB). Use of methylphenidate forthe treatment of attention deficit disorder. In: Report of the International NarcoticsControl Board for 1995. UN Doc. No. E/INCB/1995/1:II.B.4. [http://www.incb.org/e/ar/1995/menu.htm]
4. Shrag, P. & Divoky, D. (1975). The myth of the hyperactive child. New York: Pantheon.
5. Moser, R. (1974). The continuing search: FDA drug information survey. JAMA, 229(10) 1336-1338.
6. McCue, J., Hansen, C., Gal, P. (1986). Physicians' opinions of the accuracy, accessibility and frequency of use of ten sources of new drug information. Southern Medical Journal, 79(4) 441-443.
7. Peay, M. & Peay, E. (1988). The role of commercial sources in the adoptionof a new drug. Social Science and Medicine, 26(12) 1183-1189.
8. Orlowski, J. & Wateska, L. (1992). The effects of pharmaceutical firm enticementson physician prescribing patterns: There's no such thing as a free lunch. Chest, 102, 270-273.
9. Goenuel, F., Carter, F., et al. (2001). Promotion of prescription drugs andits impact on physicians' choice behavior. Journal of Marketing, 65(3) 79-90.
10. Kravitz, R., Epstein, R., et al. (2005). Influence of patients' requests fordirect-to-consumer advertised anti-depressants. British Medical Journal, 293(16), 1995-2002.
11. Caudill, T. S., Johnson, M., et al. (1996). Physicians, pharmaceutical salesrepresentatives, and the cost of prescribing. Archives of Family Medicine, 5(4) 201-206.
12. Cormack, M. & Howells, E. (1992). Factors linked to the prescribing ofbenzodiazepines by general practice principals and trainees. Journal of FamilyPractice, 9(4) 466-471.
13. Bower, A. & Burkett, G. (1987). Family physicians and generic drugs: astudy of recognition, information sources, prescribing attitudes and practices. Journal of Family Practice, 24(6) 612-616.
14. Singh, I. (2002). Bad boys, good mothers and the 'miracle' of Ritalin. Science inContext, 15(4), 577-603.
15. Bradley, C. (1937). The behavior of children receiving Benzedrine. AmericanJ. of Psychiatry, 94, 577-585.
16. Bradley, C. & Bowen, M. (1940). Amphetamine (Benzedrine) therapy ofchildren's behavior disorders. American J. of Orthopsychiatry, 11, 92-103.
17. Bender, L. & Cottingham, F. (1942). The use of amphetamine sulfate (Benzedrine) in child psychiatry. American J. of Psychiatry, 99, 116-121.
18. Lauffer, M. & Denhoff, E. (1957). Hyperkinetic behavior syndrome in children. Journal of Pediatrics, 50, 463-475.
19. Singh, 2002.
20. Hall, A.L. (2005). Welcome to ordinary? Marketing better boys. American J. of Bioethics, 5(3), 59-60.
21. Metzl, J. (2003). Prozac on the couch. Durham, NC: Duke UP.
22. Smith, M. (1991). A social history of the minor tranquilizers. Binghamton, NY: Haworth Press.
23. Conrad, P. & Schneider, J. (1980/1992). Deviance and medicalization. Philadelphia: Temple University Press.
24. Kindlon, D. & Thompson, M. (1999). Raising cain: Protecting the emotionallives of boys. New York: Ballantine Books.
25. Pollack, W. (1998). Real boys: Rescuing our sons from the myths of boyhood. New York: Random House.
26. Metzl, 2003.
27. Singh, 2002.
28. Romano, S. (1998). A glaring oversight: The use of stimulant medicationsin child psychiatry without controlled testing. Unpublished paper.
29. Metzl, 2003.
30. Lauffer & Denhoff, 1957.
31. Connors, K. & Eisenberg, L. (1963). The effects of methylphenidate onsymptomatology and learning in disabled children. American J. of Psychiatry, 120, 458-464.
32. Eisenberg, L. (1964). Role of drugs in treating disturbed children. Children, 2(5), 167-173.
33. "Those Mean Little Kids," Time, 1968;
34. "Too Many Drugs," Time, 1961;
35. "PepPills for Students," Newsweek, 1970.
36. Moynihan, R. & Cassels, A. (2005). Selling sickness: How the world's biggestpharmaceutical companies are turning us all into patients. New York: NortonBooks.
37. Watson, J. (1928). Psychological care of infant and child. New York: Norton.
38. Strecker, E. (1946). Their mothers' sons. New York: Lippincott.
39. Fromm-Reichmann, F. (1948). Notes on the development of treatment ofschizophrenics by psychoanalytic psychotherapy. Psychiatry, 11, 263-273.
40. Bowlby, J. (1970). Child care and the growth of love. (2nd ed.) Harmondsworth: Pelican.
41. Department of Health, Education and Welfare. (1971). "Report on theconference on the use of stimulant drugs in the treatment of behaviorally disturbedyoung children." Office of Child Development and the Office of the AssistantSecretary for Health and Scientific Affairs (January).
42. Shrag & Divoky, 1975.
43. Connors, C. K. (ed.) (1974). Clinical use of stimulant drugs in children: Proceedingsof a symposium held at Key Biscayne, Florida, 5-8 March 1972 (InternationalCongress Series). New York: Elsevier.
44. Wender, P. (1971). Minimal brain dysfunction in children. New York:Wiley-Interscience.
45. Connors, 1974.
46. Rose, 2004.
47. Smith, 1991.
48. Klawiter, M. (2006). The biopolitics of risk and the configuration of users: Clinical trials, pharmaceutical technologies, and the new consumption-junction. In S. Frickel & K. Moore, eds. The New Political Sociology of Science: Institutions, Networks and Power. Madison: University of Wisconsin Press, 432-460.
49. Angell, M. (2004). The truth about drug companies: How they deceive us andwhat to do about it. New York: Random House.
50. Novak, V. (2001). "New Ritalin ad blitz makes parents jumpy." Time (10 September), 62-63.
51. Singh, I. (2004). Doing their jobs: Mothering with Ritalin in a culture ofmother-blame. Social Science and Medicine, 59, 1193-1205.